z-logo
open-access-imgOpen Access
Recent Advances in Approved, Withdrawn, Experimental and Investigational Drugs in Clinical Trials for Alzheimer’s disease
Author(s) -
Rajlaxmi Deshpande
Publication year - 2022
Publication title -
medicinal and analytical chemistry international
Language(s) - English
Resource type - Journals
ISSN - 2639-2534
DOI - 10.23880/macij-16000174
Subject(s) - donepezil , memantine , rivastigmine , galantamine , acetylcholinesterase , pharmacology , medicine , prodrug , acetylcholine , neuroscience , alzheimer's disease , disease , chemistry , psychology , dementia , biochemistry , enzyme

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom